Adam Dmytriw Awarded Grant

Categories: Research
For rare aneurysms, the medical community often has a more difficult time generating strong evidence for the optimal treatment. One year ago, I started working with Research Fellow Dr. Nimer Adeeb and Clinical Fellow Dr. Christoph Griessenauer at Beth Israel Deaconess Medical Center. We realized that in order to analyze enough of these patients, we …

Read More

Aneurysm Leads to New Career

Categories: Research
Frank Garcea was 17 years old and excited to soon begin his senior year of high school in Rochester, New York, where he played on the soccer team. One hot July day, he and some fellow teammates were playing soccer for fun when Frank experienced a pounding headache and pain radiating up the back of …

Read More

Psychological Recovery Study

Categories: Research
Psychological Recovery after Aneurysmal Subarachnoid Haemorrhage: The Moderating effects of Post-traumatic Growth. This project is being conducted by a student researcher Ms Joanne Thorburn as part of a PhD study at Victoria University under the supervision of Professor Jenny Sharples and Dr Kim Shearson from the Psychology discipline, College of Health and Biomedicine, Victoria University. Project explanation …

Read More

The MASH Study

Categories: Research
For many aneurysm patients, memory problems persist despite a recovery in physical function. This can be disabling and interfere with daily life. Currently, there are no proven, effective or accessible treatment options available. The Memory training in Aneurysmal Subarachnoid Hemorrhage Patients (MASH) study aims to scientifically test whether periodic online cognitive exercises (administered through Lumosity) …

Read More

NEWTON 2 Study Details

Categories: Research
Title: Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage (NEWTON 2)  Details: Edge Therapeutics is recruiting patients who have suffered an aneurysmal subarachnoid hemorrhage (aSAH) resulting from a ruptured brain aneurysm for the Phase 3 NEWTON 2 study of EG-1962, a therapy in development to improve health …

Read More